Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | +2.09% |
|
+2.14% | +15.06% |
24/06 | Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise | MT |
24/06 | Transcript : Rani Therapeutics Holdings, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.06% | 10Cr | |
+17.23% | 12TCr | |
+18.35% | 11TCr | |
+19.62% | 2.57TCr | |
-25.40% | 1.9TCr | |
-20.21% | 1.58TCr | |
-19.53% | 1.53TCr | |
-47.37% | 1.49TCr | |
+61.46% | 1.48TCr | |
+5.23% | 1.41TCr |
- Stock Market
- Equities
- RANI Stock
- News Rani Therapeutics Holdings, Inc.
- HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating